Targeted Low Dose Chemo
In this video, Les Breitman spends about 23 minutes speaking on "Targeted Low Dose Chemo" at the 37th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Les Breitman
LES BREITMAN, M.D. received his Medical Degree from California College of Medicine, University of California at Irvine in 1964. He then completed his Internship at Santa Monica Hospital, California in 1965.
Dr. Breitman became enamored with the Practice of Complementary/Integrative Medicine and in particular Preventive and Anti-Aging Medicine. He then founded the Institute for Anti-Aging Medicine in Vista, California. He is currently directing the Integrative Cancer and Medical Treatment Center in Oceanside, California, which he Co-Founded with Juergen Winkler, M.D. in 2005. At his Clinic he treats with Nutritional Therapies, Oxidative Therapies and Hormone Therapies, including (HGH) Human Growth Hormone. HGH is a veritable fountain of youth.
The Institute also offers (IPT) Insulin Potentiation Therapy, which is an innovative cancer treatment modality that allows physicians to take advantage of the powerful cell-killing effects of conventional chemotherapy drugs – but with much lower dosages and without all their devastating side effects. Because cancer cells have a greater number of insulin receptors, insulin can interact much more strongly with cancer cells. The effect is to greatly strengthen the impact of chemotherapy directly on cancer cells, with little effect on normal tissue. The program includes Nutrition, Detoxification and Stress Reduction Programs for a comprehensive cancer care.
Dr. Breitman may be contacted at his Clinic by phone 760-439-9955, website, www.ipthealing.com and e-mail [email protected].
Transcription
Now, once again, it's a pleasure to be here and thank you for that introduction. Frank, is is now the time I try to sign that toll bridge that I could use?
Okay. You came here to hear me speak about IPT insulin potentiation therapy, now called low dose targeted chemotherapy. But before I do that, I'd like to take one minute to speak about conventional chemotherapy so that you get the distinction between the two types. Both of them are forms of chemotherapy. In conventional chemotherapy, what the oncologists does is he picks one drug and he gives the patient, he administers an overwhelming Lihi dosage of that drug in order to kill the cancer cells. Of course, because of the overwhelming toxicity, he knocks off the immune system as well. Now, sometimes they use one drug on day one and a second drug on days two, three or four. And it takes a long time to administer them. Sometimes they're administered in the hospital because they have to be administered very slowly because of their overwhelming toxicity. And then they must wait several weeks for the immune system to recover so they can do a second course. Now, I tried them and I ask them many.
Some of you are my patients. So you've heard me say this before. I tried them and I ask, well, what do you guys think the cancer cells are doing during this hiatus? You think they're on a coffee break? You think they are vacation now? They're regrouping. They're going strong. And not only that, they're getting resistance to the chemotherapeutic agents. You used. They have that ability, which I'll discuss in a moment.
And contradicts contradistinction from what conventional chemotherapy is. And by the way, I don't call it conventional oncology, I call conventional chemotherapy because that's all they do is chemotherapy. They don't do diet like Dr. Schreck just described or hormones or anything else. It's strictly chemotherapy. No Agence. In fact, many times they hear them say diet doesn't matter. Don't they understand the cancer cells thrive on glucose? As a matter of fact. That's the principle upon which low dose chemotherapy works.
You see, a cancer cell has 16 times the number of insulin receptors on its cell surface compared to the normal cell insulin brains, glucose across the cell membrane through the interior of the cell. So it could be metabolized by the cancer cell, by any cell. But the cancer cell has 16 times the number of receptors. Someone, the battle for glucose, the cancer cell wins hands down. And that is why you see at the end throes of cancer, when a patient is in